BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 14568003)

  • 21. Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
    Dyer DG; Dunn JA; Thorpe SR; Lyons TJ; McCance DR; Baynes JW
    Ann N Y Acad Sci; 1992 Nov; 663():421-2. PubMed ID: 1482072
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
    Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
    Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease.
    Smith MA; Richey PL; Taneda S; Kutty RK; Sayre LM; Monnier VM; Perry G
    Ann N Y Acad Sci; 1994 Nov; 738():447-54. PubMed ID: 7832455
    [No Abstract]   [Full Text] [Related]  

  • 24. Toward a Maillard reaction theory of aging.
    Monnier VM
    Prog Clin Biol Res; 1989; 304():1-22. PubMed ID: 2675024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.
    Brings S; Fleming T; Freichel M; Muckenthaler MU; Herzig S; Nawroth PP
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bimolecular interaction of argpyrimidine (a Maillard reaction product) in in vitro non-enzymatic protein glycation model and its potential role as an antiglycating agent.
    Bhattacherjee A; Dhara K; Chakraborti AS
    Int J Biol Macromol; 2017 Sep; 102():1274-1285. PubMed ID: 28487198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary advanced glycation end products and aging.
    Luevano-Contreras C; Chapman-Novakofski K
    Nutrients; 2010 Dec; 2(12):1247-65. PubMed ID: 22254007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").
    Miyata T
    Bull Mem Acad R Med Belg; 2002; 157(3-4):189-96; discussion 196-8. PubMed ID: 12508715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Maillard or browning reaction in diabetes.
    John WG; Lamb EJ
    Eye (Lond); 1993; 7 ( Pt 2)():230-7. PubMed ID: 7607341
    [No Abstract]   [Full Text] [Related]  

  • 30. [Advanced glycation end products or Maillard products].
    Wautier JL
    Rev Prat; 1998 Nov; 48(17):1865-7. PubMed ID: 9854387
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonenzymatic glycation of collagen in aging and diabetes.
    Reiser KM
    Proc Soc Exp Biol Med; 1991 Jan; 196(1):17-29. PubMed ID: 1984239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of advanced Maillard reaction products and their pathological role.
    Monnier VM; Nagaraj RH; Portero-Otin M; Glomb M; Elgawish AH; Sell DR; Friedlander MA
    Nephrol Dial Transplant; 1996; 11 Suppl 5():20-6. PubMed ID: 9044302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia.
    Monnier VM; Sell DR; Nagaraj RH; Miyata S; Grandhee S; Odetti P; Ibrahim SA
    Diabetes; 1992 Oct; 41 Suppl 2():36-41. PubMed ID: 1526333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary advanced glycation end products (dAGEs): An insight between modern diet and health.
    Tian Z; Chen S; Shi Y; Wang P; Wu Y; Li G
    Food Chem; 2023 Jul; 415():135735. PubMed ID: 36863235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological modulation of AGEs: a unique role for redox-active metal ions.
    Weiss MF; Saxena AK; Monnier VM
    Perit Dial Int; 1999; 19 Suppl 2():S62-7. PubMed ID: 10406496
    [No Abstract]   [Full Text] [Related]  

  • 36. Dietary Advanced Glycosylation End-Products (dAGEs) and Melanoidins Formed through the Maillard Reaction: Physiological Consequences of their Intake.
    Delgado-Andrade C; Fogliano V
    Annu Rev Food Sci Technol; 2018 Mar; 9():271-291. PubMed ID: 29350563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis.
    Lalla E; Lamster IB; Drury S; Fu C; Schmidt AM
    Periodontol 2000; 2000 Jun; 23():50-62. PubMed ID: 11276765
    [No Abstract]   [Full Text] [Related]  

  • 38. Advanced glycation end products in uremia.
    Henle T; Miyata T
    Adv Ren Replace Ther; 2003 Oct; 10(4):321-31. PubMed ID: 14681861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality Criteria for Studies on Dietary Glycation Compounds and Human Health.
    Hellwig M; Humpf HU; Hengstler J; Mally A; Vieths S; Henle T
    J Agric Food Chem; 2019 Oct; 67(41):11307-11311. PubMed ID: 31514500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Maillard reaction. Pathogenic effects].
    Voyer LE; Alvarado C
    Medicina (B Aires); 2019; 79(2):137-143. PubMed ID: 31048279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.